Ms. Satomi Yagi is reviewer in Office of New Drug IV, Pharmaceuticals and Medical Devices Agency (PMDA). She is involved in the review of CMC of small molecules. She is the lead of PMDA ICH Q12 Working Group and is MHLW/PMDA Topic Lead for ICH Q12 Implementation Working Group.